Evidence map›Paper›PMID 26236024›Full record

ArticleBrain research2015

Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity.

Neil U Parikh, R Aalinkeel, J L Reynolds, B B Nair, D E Sykes, M J Mammen, S A Schwartz, S D Mahajan

Abstract read
In one paragraph

Article in Brain research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Role of Microglia in Psychostimulant Addiction.Current neuropharmacology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The impact of erdosteine on cisplatin-induced ototoxicity: a proteomics approach.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Neil U ParikhDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
R AalinkeelDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
J L ReynoldsDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
B B NairDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
D E SykesDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
M J MammenDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
S A SchwartzDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA.
S D MahajanDepartment of Medicine, Division of Allergy, Immunology, and Rheumatology, State University of New York at Buffalo, Clinical Translational Research Center, 875 Ellicott Street, Buffalo, NY 14203, USA. Electronic address: smahajan@buffalo.edu.
University at Buffalo, State University of New York · US

Funding

A novel phase and spectroscopic imaging technique to evaluate mitochondrial dynamicsR01DA047410 · NIDA · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI KHMALADZE, ALEXANDER, MAHAJAN, SUPRIYA DINKAR · 2019 to 2021
$1.1M
Innovative Nanotherapy for Drug addiction.R21DA030108 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MAHAJAN, SUPRIYA DINKAR · 2010 to 2011
$390k
NIDA NIH HHS 1R21DA030108-01NIDA NIH HHS R01 DA047410NIDA NIH HHS R21 DA030108
6 · The paper itself

Abstract

Methamphetamine (Meth) abuse can lead to the breakdown of the blood-brain barrier (BBB) integrity leading to compromised CNS function. The role of Galectins in the angiogenesis process in tumor-associated endothelial cells (EC) is well established; however no data are available on the expression of Galectins in normal human brain microvascular endothelial cells and their potential role in maintaining BBB integrity. We evaluated the basal gene/protein expression levels of Galectin-1, -3 and -9 in normal primary human brain microvascular endothelial cells (BMVEC) that constitute the BBB and examined whether Meth altered Galectin expression in these cells, and if Galectin-1 treatment impacted the integrity of an in-vitro BBB. Our results showed that BMVEC expressed significantly higher levels of Galectin-1 as compared to Galectin-3 and -9. Meth treatment increased Galectin-1 expression in BMVEC. Meth induced decrease in TJ proteins ZO-1, Claudin-3 and adhesion molecule ICAM-1 was reversed by Galectin-1. Our data suggests that Galectin-1 is involved in BBB remodeling and can increase levels of TJ proteins ZO-1 and Claudin-3 and adhesion molecule ICAM-1 which helps maintain BBB tightness thus playing a neuroprotective role. Galectin-1 is thus an important regulator of immune balance from neurodegeneration to neuroprotection, which makes it an important therapeutic agent/target in the treatment of drug addiction and other neurological conditions.

Indexed as

BrainCapillary PermeabilityCells, CulturedCell SurvivalCentral Nervous System StimulantsClaudin-5CREB-Binding ProteinCytokinesDrug InteractionsEndothelial CellsGalectin 1Gene Expression RegulationHumansIntercellular Adhesion Molecule-1MethamphetamineNeuroprotective AgentsCentral Nervous System StimulantsClaudin-5CREB-Binding ProteinCytokinesGalectin 1Intercellular Adhesion Molecule-1MethamphetamineNeuroprotective AgentsReactive Oxygen SpeciesRNA, MessengerTJP1 protein, humanZonula Occludens-1 ProteinBlood brain barrierGalectin-1Human brain microvascular endothelial cellsMethamphetamineOxidative stressProinflammatory cytokinesTight junctionsTransendothelial electrical resistance

Identifiers

PMID26236024
PMCPMC4630155
OpenAlexW1073627852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.